A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects

Objective: This study was conducted to compare the pharmacokinetics, safety and immunogenicity of HOT-1010 with bevacizumab (Avastin®) in Chinese healthy male subjects. Methods: A single-center, randomized, double-blind, single-dose, parallel trial was performed in 84 Chinese healthy male subjects w...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Kai, Que, Linling, Ding, Ying, Chu, Nannan, Qian, Zhenzhong, Shi, Yunfei, Qin, Wei, Li, Zhenni, Chen, Yuanxin, Gu, Xianghong, Wang, Jiakun, Zhang, Lin, Zhang, Jisheng, Zhu, Xiangyang, Yang, Yongmin, Tang, Yuan, He, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245695/
https://www.ncbi.nlm.nih.gov/pubmed/34220519
http://dx.doi.org/10.3389/fphar.2021.694375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245695/
https://www.ncbi.nlm.nih.gov/pubmed/34220519
http://dx.doi.org/10.3389/fphar.2021.694375

Ejemplares similares